Apnimed, Inc. (APMD)

27.33 -1.67 (-5.76%) USD  |  NASDAQ  |  Sep 21, 09:56
More

Apnimed Total Expenses (Quarterly)

Total Expenses (Quarterly) Chart

View Total Expenses (Quarterly) for APMD.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Expenses (Quarterly) Chart
Start Trial

Historical Total Expenses (Quarterly) Data

View and export this data back to 2025. Start Trial.
Date Value
June 30, 2026 --
March 31, 2026 --
Date Value
June 30, 2025 --
March 31, 2025 --

Total Expenses (Quarterly) Range, Past 5 Years

View Total Expenses (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Expenses (Quarterly) Benchmarks

View Total Expenses (Quarterly) Benchmarks
Start Trial
IGC Pharma, Inc. Upgrade
Cocrystal Pharma, Inc. Upgrade
CNBX Pharmaceuticals, Inc. Upgrade
GB Sciences, Inc. --
Arvinas, Inc. Upgrade

Total Expenses (Quarterly) Related Metrics

Net Income (Quarterly) Upgrade
Revenue (Quarterly) Upgrade
EPS Diluted (Quarterly) Upgrade
Enterprise Value Upgrade
Gross Profit Margin (Quarterly) Upgrade
Earnings Yield Upgrade
Operating Earnings Yield Upgrade
Normalized Earnings Yield Upgrade